0.59
Retractable Technologies Inc stock is traded at $0.59, with a volume of 18,544.
It is down -0.52% in the last 24 hours and down -13.24% over the past month.
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety medical products for the healthcare industry in the United States and internationally. It principally offers VanishPoint safety products comprising tuberculin, insulin, and allergy antigen syringes; autodisable syringes; IV catheters; blood collection tube holders; and blood collection sets, as well as Patient Safe products, including syringes and Luer caps. The company also develops EasyPoint needles. In addition, it is developing retractable needles and syringes, glass syringes, dental syringes, and IV catheter introducers. Retractable Technologies, Inc. serves healthcare providers, such as acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, long-term care facilities, veterans administration facilities, military organizations, public health facilities, and prisons. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was founded in 1994 and is headquartered in Little Elm, Texas.
See More
Previous Close:
$0.5931
Open:
$0.59
24h Volume:
18,544
Relative Volume:
0.30
Market Cap:
$17.66M
Revenue:
$37.15M
Net Income/Loss:
$-6.29M
P/E Ratio:
-2.7089
EPS:
-0.2178
Net Cash Flow:
$-7.41M
1W Performance:
-10.88%
1M Performance:
-13.24%
6M Performance:
-14.27%
1Y Performance:
-39.67%
Retractable Technologies Inc Stock (RVP) Company Profile
Name
Retractable Technologies Inc
Sector
Industry
Phone
972-294-1010
Address
511 Lobo Lane, Little Elm, TX
Compare RVP vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
RVP
Retractable Technologies Inc
|
0.59 | 17.66M | 37.15M | -6.29M | -7.41M | -0.2178 |
|
ISRG
Intuitive Surgical Inc
|
426.15 | 150.55B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
192.66 | 52.48B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
RMD
Resmed Inc
|
241.45 | 33.96B | 5.54B | 1.52B | 1.74B | 10.37 |
|
ALC
Alcon Inc
|
66.65 | 32.22B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
36.59 | 32.11B | 29.14B | 1.07B | 1.05B | 1.1956 |
Retractable Technologies Inc Stock (RVP) Latest News
Retractable declares $57,611.25 total dividend to Series II & III Class B holders - TradingView
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders - finance.yahoo.com
Covalon Technologies Ltd. (COV.V) Stock Price, News, Quote & History - Yahoo! Finance Canada
Retractable Needle Safety Mechanisms Market To 2035: Safety Mandates Drive GrowthNews and Statistics - IndexBox
Breaking News about Lument Finance Trust, Inc. Common Stock (NYSE:LFT) - FinancialContent
MasterCraft Guides to Up to $32 Million Adjusted EBITDA for Transition Period - minichart.com.sg
RVP Q3 2023 Earnings: $0.14 Per-Share Loss and Flat Stock Reaction Signal Uncertain OutlookPositive Surprise Momentum - dars.gov.et
RVP Q3 2023 Earnings: $0.14 Per-Share Loss and Flat Stock Reaction Signal Uncertain OutlookROIC Trend Report - www.dars.gov.et
Rest-Of-Europe Blood Collection Devices Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets
Top Envirotech Vehicles (AZIO) Competitors 2026 - marketbeat.com
Retractable Technologies, Inc. Supports Senator Blackburn's ONSHORE Manufacturing Act - marketscreener.com
A proposed bill would offer tax breaks to make more medical supplies in the U.S. - Stock Titan
Retractable Technologies, Inc. Supports Senator Blackburn’s ONSHORE Manufacturing Act - finance.yahoo.com
Retractable Technologies Inc. (RVP) Peer Comparison – Compare with Others - Value Research
Stock Market News for Sep 3, 2026 - Stock Titan
Syringe Tip Covers Market Outlook to 2035 - IndexBox
TELA Bio Announces $17 Million Annual Cost Reduction and CFO Change Amid Restructuring - Kalkine Media
Retractable Technologies Inc. (RVP) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Retractable Technologies (RVP) Edges Up 1.14% to $0.73, Holding Above Key SupportStock News - dars.gov.et
Retractable Technologies Inc. (RVP) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com
Retractable (RVP): Stays Close to Unchanged at $0.73 in the Available Record; Current Setup: $0.69 and $0.77 Define the Nearby Reference LevelsCTA Positioning - dars.gov.et
RVP Stock Gains Post Q2 Earnings Despite Fall in Sales & Unit Volumes - Barchart.com
RVP Stock Gains Post Q2 Earnings Despite Fall in Sales & Unit Volumes - Yahoo Finance Singapore
RVP Stock Gains Post Q2 Earnings Despite Fall in Sales & Unit Volumes - Zacks Investment Research
RVP Stock Gains Post Q2 Earnings Despite Fall in Sales & Unit Volumes - Yahoo Finance
RVP Stock Gains Post Q2 Earnings Despite Fall in Sales & Unit Volumes - The Globe and Mail
RVP Stock Gains Post Q2 Earnings Despite Fall in Sales & Unit Volumes - TradingView
Retractable Technologies’ operating loss hits USD 5.1M in Q2 2026 - Medical Buyer
Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026 - marketscreener.com
Sterilizing Needle and Cannula Market to Reach 250 Index by 2035 on Biopharma Capacity Build-Out - IndexBox
Retractable Technologies Q2 EPS $0.09; Sales Fall 31% YoY - scanx.trade
Retractable Technologies: Q2 Earnings Snapshot - marketscreener.com
Retractable Technologies: Q2 Earnings Snapshot - AOL.com
Retractable Technologies: Q2 Earnings Snapshot - Enidnews.com
Retractable Technologies: Q2 Earnings Snapshot - KING5.com
Retractable Technologies Reports $6.4M Equity-Sale Gain in Q2 - Stock Titan
Retractable Technologies (RVP) swings to Q2 profit despite revenue drop and tariffs - Stock Titan
Retractable Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Vaccine Administration Market to Reach US$ 12.4 Billion by 2033 at 9.2% CAGR - openPR.com
Retractable Technologies, Inc (RVP) Debt 2025: $896K, down 0.5% - Stock Titan
Retractable Technologies, Inc. Results for the Periods Ended June 30, 2026 - finance.yahoo.com
Retractable Technologies: Q2 Earnings Snapshot - finance.yahoo.com
Retractable Technologies (RVP) Consolidates at $0.68 Amid Narrow Trading RangeLow Vol Factor - vinanet.vn
Rest-Of-Europe Blood Collection Devices Market Size, Share,Trends, Growth Analysis Report, 2030 - marketsandmarkets.com
Australia Blood Collection Devices Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets
Retractable Technologies (RVP) Consolidates at $0.68 Amid Narrow Trading RangeVolume Profile - careplusvn.com
Retractable Technologies (RVP) Consolidates at $0.68 Amid Narrow Trading RangeIchimoku Entry - dars.gov.et
Luer-Slip Syringe Tips Market Growth Driven by Clinical Diagnostics Through 2035News and Statistics - IndexBox
Sterile Fill Needles Market Growth to 2035 Driven by Biopharma Manufacturing ExpansionNews and Statistics - IndexBox
Retractable Technologies Inc (RVP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Retractable Technologies Inc Stock (RVP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Retractable Technologies Inc Stock (RVP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SHAW THOMAS J | PRESIDENT AND CEO |
Nov 11 '25 |
Buy |
0.81 |
100 |
81 |
15,825,491 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Nov 05 '25 |
Buy |
0.83 |
7,500 |
6,195 |
15,825,391 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Oct 30 '25 |
Buy |
0.86 |
15,000 |
12,915 |
15,817,891 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Oct 28 '25 |
Buy |
0.92 |
35,000 |
32,028 |
15,802,891 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Oct 27 '25 |
Buy |
0.94 |
34,506 |
32,522 |
15,767,891 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Oct 23 '25 |
Buy |
0.95 |
356 |
339 |
15,733,385 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Oct 22 '25 |
Buy |
0.96 |
10,000 |
9,600 |
15,733,029 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Oct 14 '25 |
Buy |
0.93 |
14,204 |
13,147 |
15,723,029 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Oct 08 '25 |
Buy |
0.92 |
30,000 |
27,699 |
15,708,825 |
| SHAW THOMAS J | PRESIDENT AND CEO |
Sep 29 '25 |
Buy |
0.82 |
5,000 |
4,100 |
15,678,825 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):